Trial Profile
Comparative Bioavailability of TRx0037 and TRx0014 in Healthy Elderly Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Methylthioninium chloride-TauRx (Primary) ; TRx 0037 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors TauRx Therapeutics
- 10 Dec 2010 New trial record